MAR 22, 2017 2:18 PM PDT

Breast Implants Carry Risk For Rare Cancer, FDA Finds

WRITTEN BY: Xuan Pham

The Food and Drug Administration recently highlighted a link between breast implants and a rare cancer that’s claimed at least 9 lives.

The cancer is known as anaplastic large cell lymphoma (ALCL), and is considered a rare form of non-Hodgkin's lymphoma. In total, since February 1 of this year, 359 cases of such cancer have been reported, including 9 deaths.

Importantly, the FDA makes a clear distinction that the deaths were not caused by breast cancer. Rather, the malignant cells can be found in the scar tissues surrounding the breast implant.

"All of the information to date suggests that women with breast implants have a very low but increased risk of developing ALCL compared to women who do not have breast implants," wrote the FDA.

They also highlighted another interesting link concerning the type of breast implants that seemed to be more associated with cancer. Textured implants – those with a pebbly surface designed to minimize shifting post-surgery – seem to increase the risk of cancer development.

“When we take these out, you can hear a peeling sound,” said Dr. Alex Wong, a plastic surgeon and researcher at the University of Southern California’s Keck School of Medicine. “Whereas with a smooth implant, it’s like Jell-O. You can spin it around. It moves really easily.”

“We’re still trying to find out why the surface matters,” said Dr. Wong. It’s not hard to imagine, however, that cells can better attach and nest into textured surfaces versus smooth surfaces. The content of the implant – silicone or saline – does not seem to influence cancer development.

The FDA’s announcement marks a more conclusive update on this matter, which was raised back in 2011. However, at the time, researchers did not have enough evidence to suggest a possible link.

Fortunately, the cancer seems to be rare and not commonly fatal. The FDA suggests that removing the diseased tissue and implants is sufficient for most affected women, although some do require extended cancer treatments. Further, they note that women with implants who don’t show symptoms – lumps, pain, swelling of the breast area – are likely at low risk for the cancer.

Additional sources: CNN, The New York Times

About the Author
  • I am a human geneticist, passionate about telling stories to make science more engaging and approachable. Find more of my writing at the Hopkins BioMedical Odyssey blog and at TheGeneTwist.com.
You May Also Like
MAR 16, 2020
Cancer
MAR 16, 2020
Aspirin associated with reduced risk of liver cancer
A study published in the New England Journal of Medicine from scientists collaborating from the Karolinska Institutet, i ...
MAR 18, 2020
Cancer
MAR 18, 2020
Statins could reduce heart damage from breast cancer treatment
Cancer treatments have a lot of side effects. For breast cancer chemotherapies that use drugs like anthracycline an ...
MAR 19, 2020
Cancer
MAR 19, 2020
Declining death rates for melanoma
Fewer people are dying from melanoma in the United States, suggests new research from the Perlmutter Cancer Center at NY ...
MAY 01, 2020
Cancer
MAY 01, 2020
Cancer patients' high mortality from COVID-19
A study published today in the online edition of Cancer Discovery reports that people with cancer who develop COVID-19 a ...
MAY 12, 2020
Clinical & Molecular DX
MAY 12, 2020
Could Catching the Flu Be Linked to an Increased Cancer Risk?
Results from a new research study suggest that a spike in infections such as influenza could be linked to the risk of de ...
MAY 19, 2020
Cancer
MAY 19, 2020
Great ape genomes closer to human tumors than human genomes
A new study analyzing cancer from an evolutionary perspective reports that the distribution of mutations in human tumors ...
Loading Comments...